A population‐based study of palliative rectal cancer patients with an unremoved primary tumour: Symptoms, complications and management
Colorectal Disease · 2025
DOI: 10.1111/codi.70104 ↗At a glance
Journal article in Colorectal Disease, 2025. Written by Gustav Kejving and 5 co-authors. Institution: Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden. Major MEDLINE topics: Rectal Neoplasms, Palliative Care, Postoperative Complications. 15 references. The full text is freely available (open access, CC BY 4.0). Funded by: Swedish cancer society and Region Västerbotten.
Topics: Onkologische Pflege
Abstract (original language)
Aim
Palliative rectal cancer patients typically retain their primary tumour, as trials have concluded no survival benefit of tumour resection in non‐curative patients. This patient group is understudied regarding the natural course of the remaining tumour, particularly concerning the need of surgical management.
Method
This was a retrospective study on rectal cancer patients diagnosed between 2007 and 2020 in Region Västerbotten, Sweden. Data were obtained from the Swedish Colorectal Cancer Registry and chart review. Patients were excluded if treated with curative intent, underwent primary tumour resection, had a synchronous colorectal cancer, had locally recurrent colorectal cancer, or refused treatment. Patients were followed from diagnosis until death or end of follow‐up. Indications for palliative treatment, tumour‐related complications and surgical and oncological management were investigated, with a stratified analysis for study period and patient age.
Results
Some 156 patients remained after applying exclusion criteria. The majority had metastasized and incurable disease (76%). Almost half suffered local complications (44%) and 48% underwent surgical intervention, due to the unremoved primary tumour. Tumour perforation occurred in 7% with a significantly higher risk in patients aged ≤75 years ( p = 0.009). Bowel obstruction afflicted 23%, while 40% underwent stoma diversion. Almost half received chemotherapy (48%) and radiotherapy (42%), respectively.
Conclusion
Rectal cancer patients with an unremoved primary tumour face a substantial risk of local complications, often necessitating surgical intervention. Therefore, the benefits of surgical resection should be carefully considered, especially for patients with a longer estimated survival. Further research is needed to accurately identify patients where tumour removal might be beneficial.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden.
- Department of Diagnostics and Intervention, Oncology, Umeå University, Umeå, Sweden.
ORCID profiles: Gustav Kejving
Funding
- Swedish cancer society and Region Västerbotten
Cite
APA
Kejving, G., Sandén, G., Ljuslinder, I., Rutegård, J., Vinnars, P., & Rutegård, M. (2025). A population‐based study of palliative rectal cancer patients with an unremoved primary tumour: Symptoms, complications and management. Colorectal Disease. https://doi.org/10.1111/codi.70104
Vancouver
Kejving G, Sandén G, Ljuslinder I, Rutegård J, Vinnars P, Rutegård M. A population‐based study of palliative rectal cancer patients with an unremoved primary tumour: Symptoms, complications and management. Colorectal Disease. 2025. doi:10.1111/codi.70104
BibTeX
@article{Kejving2025,
author = {Kejving, Gustav and Sandén, Gustav and Ljuslinder, Ingrid and Rutegård, Jörgen and Vinnars, Petrus and Rutegård, Martin},
title = {A population‐based study of palliative rectal cancer patients with an unremoved primary tumour: Symptoms, complications and management},
journal = {Colorectal Disease},
year = {2025},
doi = {10.1111/codi.70104}
}
EUVIMED